Ikarian Capital, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$70,259,112
+325.5%
5,796
-96.0%
8.45%
+221.4%
Q2 2023$16,513,784
-75.3%
144,200
-70.3%
2.63%
-82.7%
Q1 2023$66,850,858
+1721.4%
485,024
+1612.4%
15.17%
+1613.8%
Q4 2022$3,670,224
-67.5%
28,324
-72.2%
0.88%
-60.6%
Q3 2022$11,276,000
+20.4%
102,009
-18.4%
2.25%
+31.5%
Q2 2022$9,369,000
-73.9%
125,000
-68.7%
1.71%
-68.1%
Q4 2021$35,962,000
+5.6%
399,400
+8.5%
5.36%
+123.5%
Q3 2021$34,051,000
+776.0%
368,196
+636.4%
2.40%
+663.4%
Q2 2021$3,887,000
-90.6%
50,000
-91.0%
0.31%
-77.5%
Q1 2021$41,441,000
-82.3%
556,034
-59.5%
1.40%
-86.5%
Q4 2020$233,897,000
+163.3%
1,371,900
+116.8%
10.31%
+60.4%
Q3 2020$88,848,000
+21206.5%
632,700
+24234.6%
6.43%
+19384.8%
Q2 2020$417,000
-95.8%
2,600
-97.5%
0.03%
-95.6%
Q1 2020$10,036,000
-24.2%
102,6000.0%0.76%
-64.8%
Q4 2019$13,240,000102,6002.14%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders